West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Location
530 Herman O. West Drive, Exton, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 23, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 281 % +4.01%
Quick Ratio 70.1 % +2.8%
Debt-to-equity 35 % +2.94%
Return On Assets 12.8 % -6.21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.9M shares -0.66%
Common Stock, Shares, Outstanding 71.9M shares -0.83%
Entity Public Float 23.9B USD -15.2%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 72.2M shares -0.82%
Weighted Average Number of Shares Outstanding, Diluted 72.6M shares -1.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.02B USD +4.92%
Research and Development Expense 71M USD +2.9%
Operating Income (Loss) 588M USD +2.92%
Nonoperating Income (Expense) 17.6M USD +28.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 604M USD +4.5%
Income Tax Expense (Benefit) 125M USD +18.9%
Net Income (Loss) Attributable to Parent 492M USD -1.58%
Earnings Per Share, Basic 6 USD/shares -0.29%
Earnings Per Share, Diluted 6 USD/shares +0.15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 629M USD +28%
Accounts Receivable, after Allowance for Credit Loss, Current 625M USD +19.2%
Inventory, Net 438M USD +9.17%
Other Assets, Current 132M USD -1.79%
Assets, Current 1.82B USD +17.6%
Deferred Income Tax Assets, Net 27.9M USD -25.8%
Property, Plant and Equipment, Net 1.74B USD +10.8%
Operating Lease, Right-of-Use Asset 97.8M USD -9.44%
Intangible Assets, Net (Excluding Goodwill) 8.9M USD -27.6%
Goodwill 111M USD +1.65%
Other Assets, Noncurrent 75.8M USD +9.38%
Assets 4.11B USD +11.7%
Accounts Payable, Current 256M USD +14%
Liabilities, Current 635M USD +23%
Deferred Income Tax Liabilities, Net 22.8M USD +143%
Operating Lease, Liability, Noncurrent 73.5M USD -10.7%
Other Liabilities, Noncurrent 75.3M USD +12.7%
Liabilities 1.05B USD +14.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -102M USD +24.9%
Retained Earnings (Accumulated Deficit) 4.26B USD +10.5%
Stockholders' Equity Attributable to Parent 3.05B USD +10.9%
Liabilities and Equity 4.11B USD +11.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 129M USD +9.48%
Net Cash Provided by (Used in) Financing Activities -147M USD +45.8%
Net Cash Provided by (Used in) Investing Activities -71.3M USD +21.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.4M USD +68.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 629M USD +28%
Deferred Tax Assets, Valuation Allowance 12.8M USD -17.4%
Operating Lease, Liability 94.9M USD -7.14%
Depreciation 39.1M USD +12.7%
Payments to Acquire Property, Plant, and Equipment 71.3M USD -21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 526M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid 107M USD -8.16%
Property, Plant and Equipment, Gross 3.23B USD +8.1%
Operating Lease, Liability, Current 21.4M USD +7.54%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.4M USD -8.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 25.4M USD +9.48%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.6M USD +7.1%
Deferred Tax Assets, Operating Loss Carryforwards 6.1M USD -39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 43.6M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.7M USD -9.93%
Operating Lease, Payments 6.1M USD +15.1%
Additional Paid in Capital 0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 165M USD +6.97%
Deferred Tax Assets, Net of Valuation Allowance 93.8M USD -4.48%
Share-based Payment Arrangement, Expense 21.4M USD +35.4%
Interest Expense 700K USD -75.9%